Koninklijke Philips Other Long-Term Assets 2010-2024 | PHG
- Koninklijke Philips other long-term assets for the quarter ending September 30, 2024 were $0.781B, a 5.34% decline year-over-year.
- Koninklijke Philips other long-term assets for 2023 were $0.774B, a 3.1% decline from 2022.
- Koninklijke Philips other long-term assets for 2022 were $0.799B, a 11.06% decline from 2021.
- Koninklijke Philips other long-term assets for 2021 were $0.898B, a 56.6% increase from 2020.
Koninklijke Philips Annual Other Long-Term Assets (Millions of US $) |
|
---|---|
2023 | $774 |
2022 | $799 |
2021 | $898 |
2020 | $573 |
2019 | $330 |
2018 | $481 |
2017 | $748 |
2016 | $473 |
2015 | $618 |
2014 | $706 |
2013 | $743 |
2012 | $827 |
2011 | $758 |
2010 | $853 |
2009 | $3,234 |
Koninklijke Philips Quarterly Other Long-Term Assets (Millions of US $) |
|
---|---|
2024-06-30 | $781 |
2023-09-30 | |
2023-06-30 | $789 |
2023-03-31 | |
2022-06-30 | $825 |
2021-06-30 | $748 |
2020-06-30 | $492 |
2019-06-30 | $428 |
2018-06-30 | $722 |
2017-06-30 | $842 |
2016-12-31 | $473 |
2016-09-30 | $487 |
2016-06-30 | $496 |
2016-03-31 | $558 |
2015-12-31 | $618 |
2015-09-30 | $607 |
2015-06-30 | $649 |
2015-03-31 | $678 |
2014-12-31 | $706 |
2014-09-30 | $698 |
2014-06-30 | $683 |
2014-03-31 | $746 |
2013-12-31 | $743 |
2013-09-30 | $878 |
2013-06-30 | $833 |
2013-03-31 | $857 |
2012-12-31 | $1,053 |
2012-09-30 | $990 |
2012-06-30 | $1,029 |
2012-03-31 | $1,012 |
2011-12-31 | $758 |
2011-09-30 | $1,002 |
2011-06-30 | $977 |
2011-03-31 | $812 |
2010-12-31 | $853 |
2010-09-30 | $3,059 |
2010-06-30 | $3,295 |
2010-03-31 | $3,534 |
2009-12-31 | $3,234 |
2009-09-30 | $1,531 |
2009-06-30 | $1,309 |
2009-03-31 | $3,730 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $24.796B | $19.663B |
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $203.382B | 25.94 |
Stryker (SYK) | United States | $148.728B | 33.52 |
Boston Scientific (BSX) | United States | $134.855B | 38.77 |
EssilorLuxottica (ESLOY) | France | $111.549B | 0.00 |
Medtronic (MDT) | Ireland | $108.676B | 16.14 |
Haleon (HLN) | United Kingdom | $43.230B | 28.09 |
Lonza Group Ag (LZAGY) | Switzerland | $42.368B | 0.00 |
GE HealthCare Technologies (GEHC) | United States | $37.464B | 19.43 |
ResMed (RMD) | United States | $35.759B | 29.39 |
Terumo (TRUMY) | Japan | $29.367B | 41.47 |
Zimmer Biomet Holdings (ZBH) | United States | $21.580B | 13.74 |
Insulet (PODD) | United States | $18.378B | 73.18 |
Baxter (BAX) | United States | $16.844B | 10.96 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.947B | 0.00 |
BellRing Brands (BRBR) | United States | $9.886B | 39.63 |
Bio-Rad Laboratories (BIO) | United States | $9.115B | 30.98 |
Demant (WILYY) | Denmark | $8.342B | 0.00 |
Lantheus Holdings (LNTH) | United States | $6.071B | 14.11 |
TG Therapeutics (TGTX) | United States | $5.378B | 0.00 |
Haemonetics (HAE) | United States | $4.291B | 20.94 |
Prestige Consumer Healthcare (PBH) | United States | $4.157B | 20.67 |
ICU Medical (ICUI) | United States | $4.134B | 39.36 |
Perrigo (PRGO) | Ireland | $3.694B | 10.88 |
Envista Holdings (NVST) | United States | $3.681B | 27.42 |
Agios Pharmaceuticals (AGIO) | United States | $3.167B | 0.00 |
Neogen (NEOG) | United States | $3.159B | 36.45 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
GN Store Nord (GNNDY) | Denmark | $2.782B | 17.84 |
QuidelOrtho (QDEL) | United States | $2.548B | 16.40 |
LeMaitre Vascular (LMAT) | United States | $2.380B | 57.85 |
Warby Parker (WRBY) | United States | $2.366B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.977B | 34.59 |
AtriCure (ATRC) | United States | $1.740B | 0.00 |
InMode (INMD) | Israel | $1.552B | 9.34 |
AdaptHealth (AHCO) | United States | $1.331B | 9.51 |
Curaleaf Holdings (CURLF) | Canada | $1.293B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.253B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.178B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.962B | 16.97 |
Owens & Minor (OMI) | United States | $0.943B | 7.37 |
National Vision Holdings (EYE) | United States | $0.910B | 30.40 |
CeriBell (CBLL) | United States | $0.904B | 0.00 |
Evolus (EOLS) | United States | $0.826B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.809B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.679B | 30.02 |
Surmodics (SRDX) | United States | $0.561B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.561B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.554B | 0.00 |
Quanterix (QTRX) | United States | $0.450B | 0.00 |
Omeros (OMER) | United States | $0.448B | 0.00 |
Canopy Growth (CGC) | Canada | $0.407B | 0.00 |
ZimVie (ZIMV) | United States | $0.379B | 31.95 |
Valneva SE (VALN) | France | $0.359B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.339B | 32.26 |
Biote (BTMD) | United States | $0.334B | 7.31 |
Sanara MedTech (SMTI) | United States | $0.326B | 0.00 |
Cerus (CERS) | United States | $0.310B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.287B | 19.25 |
Zynex (ZYXI) | United States | $0.258B | 54.07 |
Aurora Cannabis (ACB) | Canada | $0.236B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.224B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.219B | 15.12 |
High Tide (HITI) | Canada | $0.215B | 89.00 |
MacroGenics (MGNX) | United States | $0.201B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.189B | 2.67 |
Jin Medical (ZJYL) | China | $0.166B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.164B | 0.00 |
Brainsway (BWAY) | Israel | $0.164B | 98.40 |
Zevia PBC (ZVIA) | United States | $0.150B | 0.00 |
FitLife Brands (FTLF) | United States | $0.147B | 18.50 |
TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
Fonar (FONR) | United States | $0.104B | 11.75 |
Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.10 |
Veru (VERU) | United States | $0.092B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.079B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.071B | 36.67 |
Exagen (XGN) | United States | $0.069B | 0.00 |
Modular Medical (MODD) | United States | $0.067B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.065B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
InterCure (INCR) | Israel | $0.061B | 0.00 |
MariMed (MRMD) | United States | $0.059B | 0.00 |
Safety Shot (SHOT) | United States | $0.053B | 0.00 |
Apyx Medical (APYX) | United States | $0.053B | 0.00 |
Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.033B | 0.00 |
ImmuCell (ICCC) | United States | $0.033B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
Nephros (NEPH) | United States | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Sharps Technology (STSS) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 12.83 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |